share_log

Bharat Biotech has Completed Phase 2 and 3 Clinical Trials of Covaxin for Use in Children 2 to 18 Years; Chairman Krishna Ella said Covaxin Production would Reach 55M Doses in October vs 35M in Septem

Bharat Biotech has Completed Phase 2 and 3 Clinical Trials of Covaxin for Use in Children 2 to 18 Years; Chairman Krishna Ella said Covaxin Production would Reach 55M Doses in October vs 35M in Septem

巴拉特生物技術公司已經完成了用於2至18歲兒童的Covaxin的第二期和第三期臨牀試驗;董事長Krishna Ella説,Covaxin的產量將從9月的3500萬劑增加到10月份的5500萬劑
Benzinga Real-time News ·  2021/09/21 05:14

Live Mint https://www.livemint.com/news/india/bharat-biotech-completes-covaxin-phase-2-3-clinical-trials-for-children-11632213730051.html

LIVE MINT https://www.livemint.com/news/india/bharat-biotech-completes-covaxin-phase-2-3-clinical-trials-for-children-11632213730051.html

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論